David Ormesher, CEO of CG Life, highlights the renaissance in life science innovation driving the growth of health and life sciences communications. Acquisitions like Berry & Company PR and Toolhouse reflect the agency's strategic expansion to adapt to the fast-paced digital landscape.
The expansion of U.S. health care advertising, projected to reach $29.2 billion by 2028, signifies the increasing focus on personalized health content. Agencies must utilize digital platforms for effective storytelling and audience engagement to meet evolving consumer preferences.
Ormesher emphasizes the importance of leveraging technology to target audiences with personalized content in the life sciences and biopharmaceutical sectors. The shift towards PR and marketing strategies signals a new approach to connect with diverse audiences and enhance brand visibility.
[
add
]
[
|
|
...
]